Cargando…

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management

The presence of rare comorbidities in patients with cardiovascular disease (CVD) presents a diagnostic challenge to cardiologists. In evaluating these patients, cardiologists are faced with a unique opportunity to shorten diagnosis times and direct patients towards correct treatment pathways. Idiopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Cleemput, Johan, Sonaglioni, Andrea, Wuyts, Wim A., Bengus, Monica, Stauffer, John L., Harari, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824347/ https://www.ncbi.nlm.nih.gov/pubmed/30554332 http://dx.doi.org/10.1007/s12325-018-0857-z

Ejemplares similares

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
por: Caminati, Antonella, et al.
Publicado: (2019)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Recent advances in managing idiopathic pulmonary fibrosis
por: Scelfo, Chiara, et al.
Publicado: (2017)

Prognostic role of CHA(2)DS(2)-VASc score for mortality risk assessment in non-advanced idiopathic pulmonary fibrosis: a preliminary observation
por: Sonaglioni, Andrea, et al.
Publicado: (2023)

Managing comorbidities in idiopathic pulmonary fibrosis
por: Fulton, Blair G, et al.
Publicado: (2015)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
por: Cano-Jiménez, Esteban, et al.
Publicado: (2018)

The 6-min walk test as a primary end-point in interstitial lung disease
por: Harari, Sergio, et al.
Publicado: (2022)

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy
por: Harari, Sergio, et al.
Publicado: (2016)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

Severe idiopathic pulmonary fibrosis: what can be done?
por: Caminati, Antonella, et al.
Publicado: (2017)

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
por: Harari, Sergio, et al.
Publicado: (2015)

Electronically monitored medication adherence in idiopathic pulmonary fibrosis: prevalence, predictors and outcomes
por: Delameillieure, Anouk, et al.
Publicado: (2022)

Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
por: Wuyts, Wim A, et al.
Publicado: (2018)

Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis
por: Aburto, Myriam, et al.
Publicado: (2018)

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models
por: Wuyts, Wim A., et al.
Publicado: (2014)

Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
por: Mooney, Joshua, et al.
Publicado: (2019)

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
por: Richeldi, Luca, et al.
Publicado: (2020)

Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review
por: Delameillieure, Anouk, et al.
Publicado: (2021)

Patients’ and healthcare professionals’ perspectives on the idiopathic pulmonary fibrosis care journey: a qualitative study
por: Delameillieure, Anouk, et al.
Publicado: (2021)

Behavioural and psychological patterns of patients with idiopathic pulmonary fibrosis: a prospective study
por: Delameillieure, Anouk, et al.
Publicado: (2022)

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2016)

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2017)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
por: Oldham, Justin M., et al.
Publicado: (2017)

Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome
por: Bordas-Martínez, Jaume, et al.
Publicado: (2021)

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation
por: Caminati, Antonella, et al.
Publicado: (2015)

High-risk pulmonary embolism in a post-COVID 19 female under hormonal contraception
por: Sonaglioni, Andrea, et al.
Publicado: (2023)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis
por: McDonough, John E, et al.
Publicado: (2019)

Update on diagnosis and treatment of idiopathic pulmonary fibrosis
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis
por: Millan-Billi, Paloma, et al.
Publicado: (2018)

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2020)

PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in Italy
por: Vancheri, Carlo, et al.
Publicado: (2021)

Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis
por: Cordeiro, Carlos Robalo, et al.
Publicado: (2013)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
por: Moor, C. C., et al.
Publicado: (2020)

Predominant dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: to be distinguished from idiopathic pulmonary fibrosis
por: Slabbynck, Hans, et al.
Publicado: (2017)

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
por: Delanote, Isabelle, et al.
Publicado: (2016)

Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
por: Alfaro, Tiago M., et al.
Publicado: (2020)

Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
por: Lee, Jang Ho, et al.
Publicado: (2023)

Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
por: Stijn, Willems, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jgsjh1f7s21a7pjqkcqbo65isn